ArticleBMC bioinformatics2023
A prefix and attention map discrimination fusion guided attention for biomedical named entity recognition.
Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Fourier Kolmogorov-Arnold Network integrated into BioBERT-based model for Biomedical Named Entity Recognition.NPJ digital medicine · 2026Article
- Enhancing biomedical named entity recognition with parallel boundary detection and category classification.BMC bioinformatics · 2025Article
- Biomedical named entity recognition using improved green anaconda-assisted Bi-GRU-based hierarchical ResNet model.BMC bioinformatics · 2025Article
- Attention-based interactive multi-level feature fusion for named entity recognition.Scientific reports · 2025Article
- BioBBC: a multi-feature model that enhances the detection of biomedical entities.Scientific reports · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundThe biomedical literature is growing rapidly, and it is increasingly important to extract meaningful information from the vast amount of literature. Biomedical named entity recognition (BioNER) is one of the key and fundamental tasks in biomedical text mining. It also acts as a primitive step for many downstream applications such as relation extraction and knowledge base completion. Therefore, the accurate identification of entities in biomedical literature has certain research value. However, this task is challenging due to the insufficiency of sequence labeling and the lack of large-scale labeled training data and domain knowledge.
resultsIn this paper, we use a novel word-pair classification method, design a simple attention mechanism and propose a novel architecture to solve the research difficulties of BioNER more efficiently without leveraging any external knowledge. Specifically, we break down the limitations of sequence labeling-based approaches by predicting the relationship between word pairs. Based on this, we enhance the pre-trained model BioBERT, through the proposed prefix and attention map dscrimination fusion guided attention and propose the E-BioBERT. Our proposed attention differentiates the distribution of different heads in different layers in the BioBERT, which enriches the diversity of self-attention. Our model is superior to state-of-the-art compared models on five available datasets: BC4CHEMD, BC2GM, BC5CDR-Disease, BC5CDR-Chem, and NCBI-Disease, achieving F1-score of 92.55%, 85.45%, 87.53%, 94.16% and 90.55%, respectively.
conclusionCompared with many previous various models, our method does not require additional training datasets, external knowledge, and complex training process. The experimental results on five BioNER benchmark datasets demonstrate that our model is better at mining semantic information, alleviating the problem of label inconsistency, and has higher entity recognition ability. More importantly, we analyze and demonstrate the effectiveness of our proposed attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.